Characterization of Immune Response in Participants from a Posdinemab Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514634-20-00

Acronym

NOPRODALZ0005

Enrollment

Registered

2024-12-16

Start date

2025-02-25

Completion date

2026-01-08

Last updated

2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Alzheimer's disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026